Radvac Antiviral Database — Drugs, Trials, and Approvals Across All Viruses

Constituent drugs (4)

Darunavir

Could not render structureView on PubChem

3D not available

Cobicistat

Could not render structureView on PubChem

3D not available

Emtricitabine

Could not render structureView on PubChem

3D not available

Tenofovir Alafenamide

Could not render structureView on PubChem

3D not available

Chemical Identifiers

ClinicalTrials.gov PubMed

Clinical Development by Virus1

Human immunodeficiency virus 1

HIV-1

Target: Viral protease + RT

Approved (other)

Preclinical

Phase 2positive

Phase 3positive

Approved

Japan

Approval ref (pmda.go.jp) PMDA approved Jun. 18, 2019fixed-dose combination of Darunavir, Cobicistat, Emtricitabine, Tenofovir alafenamide.